Arecor Therapeutics (LON:AREC) Trading Down 0.6%

Arecor Therapeutics plc (LON:ARECGet Free Report) dropped 0.6% during trading on Thursday . The company traded as low as GBX 156.80 ($2.00) and last traded at GBX 157.50 ($2.01). Approximately 52,702 shares were traded during trading, an increase of 192% from the average daily volume of 18,033 shares. The stock had previously closed at GBX 158.50 ($2.02).

Arecor Therapeutics Stock Performance

The company has a market cap of £48.24 million, a price-to-earnings ratio of -506.65 and a beta of -0.21. The company has a debt-to-equity ratio of 3.55, a current ratio of 2.17 and a quick ratio of 6.24. The stock has a 50-day moving average price of GBX 140.10 and a 200 day moving average price of GBX 157.89.

About Arecor Therapeutics

(Get Free Report)

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Featured Stories

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.